Edwards Lifesciences Corporation Debt Securities, Available-for-sale, Amortized Cost
Edwards Lifesciences Corporation (EW) had Debt Securities, Available-for-sale, Amortized Cost of $1.35 billion as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-08-04
- 2026-06-30: Debt Securities, Available-for-sale, Amortized Cost $1.35B.
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $1.23B.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $1.30B.
- 2025-09-30: Debt Securities, Available-for-sale, Amortized Cost $1.18B.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2026-06-30 | $1.35B 10-Q · filed 2026-08-04 |
| 2026-03-31 | $1.23B 10-Q · filed 2026-05-06 |
| 2025-12-31 | $1.30B 10-Q · filed 2026-08-04 |
| 2025-09-30 | $1.18B 10-Q · filed 2025-11-05 |
| 2025-06-30 | $839.40M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $827.80M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $1.03B 10-K · filed 2026-02-25 |
| 2024-09-30 | $900.90M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $534.30M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $767.70M 10-Q · filed 2024-04-29 |
| 2023-12-31 | $926.10M 10-K · filed 2025-02-28 |
| 2023-09-30 | $1.06B 10-Q · filed 2023-10-27 |
| 2023-06-30 | $1.23B 10-Q · filed 2023-07-28 |
| 2023-03-31 | $1.36B 10-Q · filed 2023-04-28 |
| 2022-12-31 | $1.55B 10-K · filed 2024-02-12 |
| 2022-09-30 | $1.72B 10-Q · filed 2022-10-28 |
| 2022-06-30 | $1.71B 10-Q · filed 2022-07-29 |
| 2022-03-31 | $1.89B 10-Q · filed 2022-04-28 |
| 2021-12-31 | $2.19B 10-K · filed 2023-02-13 |
| 2021-09-30 | $1.40B 10-Q · filed 2021-10-29 |
| 2021-06-30 | $1.14B 10-Q · filed 2021-07-30 |
| 2021-03-31 | $914.70M 10-Q · filed 2021-04-28 |
| 2020-12-31 | $924.30M 10-K · filed 2022-02-14 |
| 2020-09-30 | $825.70M 10-Q · filed 2020-10-26 |
| 2020-06-30 | $810.00M 10-Q · filed 2020-07-27 |
| 2020-03-31 | $813.90M 10-Q · filed 2020-04-28 |
| 2019-12-31 | $790.50M 10-K · filed 2021-02-12 |
| 2019-09-30 | $526.20M 10-Q · filed 2019-10-25 |
| 2019-06-30 | $594.60M 10-Q · filed 2019-07-26 |
| 2019-03-31 | $654.60M 10-Q · filed 2019-04-26 |
| 2018-12-31 | $711.30M 10-K · filed 2020-02-14 |
| 2018-09-30 | $605.80M 10-Q · filed 2018-10-26 |
| 2018-06-30 | $583.00M 10-Q · filed 2018-07-27 |
| 2018-03-31 | $642.40M 10-Q · filed 2018-04-27 |
| 2017-12-31 | $685.30M 10-K · filed 2019-02-15 |
| 2017-09-30 | $701.60M 10-Q · filed 2017-10-27 |
| 2017-06-30 | $647.00M 10-Q · filed 2017-07-28 |
| 2017-03-31 | $577.20M 10-Q · filed 2017-04-28 |
| 2016-12-31 | $603.00M 10-K · filed 2018-02-16 |
| 2016-09-30 | $540.60M 10-Q · filed 2016-10-28 |
| 2016-06-30 | $443.90M 10-Q · filed 2016-07-29 |
| 2016-03-31 | $389.80M 10-Q · filed 2016-04-29 |
| 2015-12-31 | $364.30M 10-K · filed 2017-02-17 |
| 2015-09-30 | $345.10M 10-Q · filed 2015-10-29 |
| 2015-06-30 | $291.00M 10-Q · filed 2015-07-29 |
| 2015-03-31 | $227.20M 10-Q · filed 2015-04-29 |
| 2014-12-31 | $160.50M 10-K · filed 2016-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |